Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer

PURPOSE: We analyzed the responses of patients with locally advanced breast cancer to neoadjuvant chemotherapy (NAC) and NAC combined with neoadjuvant human epidermal growth factor receptor-2 (HER2) targeted therapy (NCHTT). METHODS: We retrospectively reviewed 59 patients with HER2 amplified locall...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Dong Hui, Lee, Se Kyung, Kim, Sangmin, Choi, Min-Young, Jung, Seung Pil, Lee, Jeonghui, Kim, Jiyoung, Koo, Min Young, Bae, Soo Youn, Kim, Jung-Han, Kim, Jee Soo, Ho, Kil Won, Lee, Jeong Eon, Nam, Seok Jin, Yang, Jung-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641366/
https://www.ncbi.nlm.nih.gov/pubmed/23646312
http://dx.doi.org/10.4174/jkss.2013.84.5.273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641366/
https://www.ncbi.nlm.nih.gov/pubmed/23646312
http://dx.doi.org/10.4174/jkss.2013.84.5.273

Ejemplares similares